CTC Cancer Research Results
CTC, Circulating-Tumour-Cells: Click to Expand ⟱
| Source: |
| Type: |
CTC provide a blood biomarker for early carcinogenesis, cancer progression and treatment effectiveness. An increase in CTCs is associated with cancer progression, a CTC decrease with cancer containment or remission.
|
Scientific Papers found: Click to Expand⟱
TumMeta↓, COX1↓, CTC↓,
CTC↓,
angioG↓, HH↓, Dose↝, PSA↓, CTC↓, other↝, toxicity↝,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
HH↓, 1,
Migration(tgid=13) ⓘ
TumMeta↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX1↓, 1, PSA↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
CTC↓, 3, PSA↓, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↝, 1,
Total Targets: 10
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CTC, Circulating-Tumour-Cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:446 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page